Estimating the efficacy of interventions to prevent mother-to-child transmission of human immunodeficiency virus in breastfeeding populations: Comparing statistical methods

American Journal of Epidemiology

Volumn 158, Issue 6, 2003, Pages 596-605

  Alioum, Ahmadou ^a   Cortina Borja, Mario ^b   Dabis, François ^a   Dequae Merchadou, Laurence ^a   Haverkamp, Geert ^c   Hughes, James ^d   Karon, John ^e   Leroy, Valeriane ^a   Newell, Marie Louise ^b   Richardson, Barbra A ^d   Van Weert, Liesbeth ^c   Weverling, Gerrit Jan ^c  

^a INSERM   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF WASHINGTON   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Breast feeding; Disease transmission; HIV; Models; Statistical; Survival analysis; Treatment outcome; Vertical

Indexed keywords

PLACEBO; ZIDOVUDINE;

BREASTFEEDING; DISEASE TRANSMISSION; STATISTICAL ANALYSIS;

ADULT; ARTICLE; BREAST FEEDING; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; EVALUATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LONG TERM CARE; MAJOR CLINICAL STUDY; META ANALYSIS; MOTHER CHILD RELATION; POPULATION RISK; POSTNATAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; VALIDATION PROCESS; VERTICAL TRANSMISSION; WEANING;

ADULT; ANTIVIRAL AGENTS; BREAST FEEDING; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MILK, HUMAN; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; STATISTICS;

EID: 0041834521     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg188     Document Type: Article

References (17)

1. Nduati R, John G, Mbori-Ngacha D, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 2000;283:1167-74.
2. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. The Working Group on Mother-to-Child Transmission of HIV. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:506-10.
3. Dabis F, Msellati P, Meda N, et al. Six-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in C6te d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mere-Enfant. Lancet 1999;353:786-92.
4. Wiktor SZ, Ekpini ER, Karon JM, et al. Randomized clinical trial of a short course of oral zidovudine to prevent mother-to-child transmission of HIV-1 in Abidjan, C6te d'Ivoire. Lancet 1999;353:781-5.
5. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802.
6. Saba J. The results of the PETRA intervention trial to prevent perinatal transmission in SubSaharan Africa. (Abstract S6). In: Program and abstracts of the 6th Conference on Retroviruses and Opportunistic Infections, Chicago, Illinois, January 31-February 4, 1999.
7. Leroy V, Newell ML, Dabis F, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Lancet 1998;352:597-600.
8. Leroy V, Karon J, Alioum A, et al. Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 2002;16:631-41.
9. Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo -controlled trial. Lancet 2002;359:1178-86.
10. Deseyve M, Duefield C, Musisi M, et al. The one year safety and efficacy data of the HIVNET 012 trial. Presented at the 13th International AIDS Conference, Durban, South Africa, July 9-14, 2000. (Abstract LbOr1).
11. Alioum A, Dabis F, Dequae-Merchadou L, et al. Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breastfeeding populations: development of a consensus methodology. Stat Med 2001;20:3539-56.
12. Armitage P, Berry G. Statistical methods in medical research. Oxford, United Kingdom: Blackwell Science, Ltd, 1994.
13. Turnbull B. The empirical distribution function with arbitrarily, grouped, censored, and truncated data. J R Stat Soc (B) 1976; 38:290-5.
14. Lindsey JC, Ryan LM. Tutorial in biostatistics: methods for interval-censored data. Stat Med 1998; 17:219-38.
15. Hudgens MG, Satten GA, Longini IM. Non-parametric maximum likelihood estimation for competing risks of survival data subject to interval censoring and truncation. Biometrics 2001; 57:74-80.
16. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York, NY: John Wiley & Sons, Inc, 1980.
17. Hughes JP, Richardson BA. Analysis of a randomized trial to prevent vertical transmission of HIV-1. J Am Stat Assoc 2001; 95:1032-43.